Physician profile
Christopher James Connor
NPI 1891080024
$1,489.19
in general payments reported to CMS, 2019-2025
7 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $121 · 2022: $137 · 2023: $97.04 · 2024: $779 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $546 · Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $545.88 |
| Food and Beverage | $534.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $725.50 | 2019-2025 | Infinion 16, General - Pain Management, Wavewriter Alpha Prime 16 |
| Curonix LLC | $563.52 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $116.07 | 2022-2024 | |
| Foundation Fusion Solutions, LLC | $32.22 | 2025 | |
| Avanos Medical | $19.58 | 2023 | Generator |
| Globus Medical, INC. | $16.99 | 2025 | Senza |
| Biotronik Nro, INC. | $15.31 | 2024 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.